Questions for the Panelists

  • What do you believe are the biggest challenges clinical practice guidelines developers/users face today? For example:

    • What do you do when the scientific evidence is absent or poor?

    • How do you reconcile disagreements in evidence interpretation among guidelines?

    • How do guidelines accommodate subgroups (e.g., older populations or persons with multimorbidities) whose treatment outcomes may differ from the average patient?

    • Are there other challenges you believe are important?

  • What topics and/or processes do you think the committee should consider in deriving quality standards for clinical practice guidelines? For example:

    • What should the composition of CPG development panels, in particular the balance of methodologists, topical experts, and consumers, look like?

    • What methods might be developed for determining which recommendations among those in a guideline should be applied to quality measures or electronic medical record decision prompts?

    • Is there an available assessment tool that adequately rates both the level of the scientific evidence and strength of clinical recommendations that should be used as standard practice in guideline development?

    • What administrative (e.g., accreditation) or legal approaches might improve the quality of clinical practice guidelines?

    • What explicit approaches might harmonize guideline developers and increase guidelines convergence?

    • What types of strategies might promote greater use of guidelines?

    • Are there other characteristics of guideline standards you think are important for the committee to consider?

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement